Guo Xiang Cheng
Chief Executive Officer at Shanghai Genon Biological Product Co., Ltd.
Profile
Guo Xiang Cheng is currently the Chairman & General Manager at Shanghai Genon Biological Product Co., Ltd., Chairman at Shanghai Rui Dong Hospital, Chairman at Shanghai Transgenic Research Center, and President-Biotechnology at Tongji University.
He holds a doctorate degree from Shanghai Jiao Tong University, conferred in 1998, and an undergraduate degree from Yangzhou University, conferred in 1985.
Guo Xiang Cheng active positions
| Companies | Position | Start |
|---|---|---|
Shanghai Genon Biological Product Co., Ltd.
 Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
| Shanghai Rui Dong Hospital | Chairman | 2010-03-09 |
| Shanghai Transgenic Research Center | Chairman | 2010-03-09 |
| Tongji University | Corporate Officer/Principal | 2010-03-09 |
Training of Guo Xiang Cheng
| Shanghai Jiao Tong University | Doctorate Degree |
| Yangzhou University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Shanghai Genon Biological Product Co., Ltd.
Shanghai Genon Biological Product Co., Ltd. BiotechnologyHealth Technology Shanghai Genon Biological Product Co., Ltd. engages in the research and development, manufacture, and sale of animal-derived protein and biological products. Its products include plasma series, blood cell series, and peptide series. Its business scope includes production of animal-derived feed products such as plasma protein powder, hemoglobin powder, and intestinal membrane protein powder; sale of concentrated feed. The company was founded on July 21, 2005 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Rui Dong Hospital | |
| Shanghai Transgenic Research Center |
- Stock Market
- Insiders
- Guo Xiang Cheng
